Michael Archer, a 35-year-old resident of St. Neots, Cambridgeshire, initially dismissed his hearing loss and muscle weakness as signs of aging. However, these symptoms led to the discovery of a rare genetic condition known as neurofibromatosis type 2 (NF2), characterized by noncancerous tumors on nerves, particularly in the brain and spinal cord.
Diagnosis and Challenges
Archer, who works as a customer success specialist for a global IT company, began experiencing symptoms after his 30th birthday. Initially, he joked about his hearing loss with colleagues, but as his coordination and muscle strength deteriorated, he sought medical advice. A physical therapist suspected a neurological issue, prompting further tests, including an MRI and blood test at Hinchingbrooke Hospital in the summer of 2024. The results revealed tumors in his brain and spinal cord, leading to his NF2 diagnosis in October 2024.
The diagnosis was a shock for Archer, who described it as life-altering. Initially, he struggled with depression and turned to alcohol to cope. The tumors compressing his spinal cord have caused stiffness and coordination issues, and he faces a difficult decision regarding surgery to remove them. The surgery, scheduled for October 2026, carries significant risks, including potential paralysis or the need for a feeding or breathing tube.
Advocacy and Awareness
Despite the challenges, Archer has turned his experience into advocacy. He uses social media to raise awareness about NF2 and connect with others affected by the condition. His efforts have led to the creation of the “F*** NF2” campaign, which raises funds for CureNF2 Corner, a charity supporting research. Archer’s story has resonated with people worldwide, offering hope and support to families dealing with similar diagnoses.
Archer’s journey underscores the importance of early medical intervention and the power of community support in facing rare medical conditions. His advocacy work aims to increase awareness and funding for NF2 research, with the hope of finding a cure.
Original reporting: KTBS 3 (Shreveport) — read the source article.
